Stimulant — methylphenidate
Jornay PM
Methylphenidate (delayed-release/extended-release, evening dose)
DEA Schedule II FDA approved adults
Pediatric ages 6+
How it works
Two-stage capsule: delayed release (~10 hours of inactivity) followed by extended release. Taken in the evening for next-morning effect.
At-a-glance
- Onset of effect
- 9–11 h
- Typical duration of effect
- 10–13 h
- Half-life
- ~6 (after onset)
- Formulations
- Oral capsule (DR-ER, taken in evening)
- Adult dose range
- 20–100 mg once nightly
FDA max: 100 mg/day
Common side effects
- Decreased appetite
- Insomnia
- Mood changes
- Headache
Important warnings
- Schedule II
- Cardiovascular risk
Notes
Designed for patients who struggle to take a stimulant first thing in the morning — the dose is taken at ~8pm and effect begins on waking.
Source
Reference data is sourced from the current FDA prescribing information at DailyMed. Dose ranges, approved ages, and warnings change over time — always check the current label and consult your prescriber.